Healthcare Biotechnology is helping you to…

Live healthier for longer by providing you with medical choices and solutions

Read more

  • More than 350 million patients around the world are already benefiting from Healthcare biotech through the use of biotech medicine to treat and prevent every day chronic illnesses including heart attacks, stroke, multiple sclerosis, breast cancer, cystic fibrosis, leukaemia, diabetes, hepatitis and other rare or infectious diseases.
  • Healthcare biotech enables the development of therapies for rare diseases that are often debilitating and life threatening which effect 20 to 30 million Europeans and their families.
  • Healthcare biotech is estimated to account for more than 20% of all marketed medicines and it is estimated that, by 2015, 50% of all medicines will come from biotech.
  • Healthcare biotech increases the effectiveness and safety of the treatments as well as reducing the use of ineffective treatments and adverse reactions through its approach on Personalised Medicine. Personalised Medicine works to diagnose what one patient’s problems are precisely and then works to better adapt the healthcare solutions to suit their specific needs.
  • Healthcare biotech comprises more than 1700 companies and a market worth more than €17 billion in Europe alone.
  • Healthcare biotech creates jobs. Between 2007and 2008, employment in all departments of companies working on the development of orphan drugs for rare disease patients in the EU more than doubled, showing an increase of 158% according to the Office of Health Economics, UK.

Industrial Biotechnology is helping you to…

Minimise mankind’s impact on the environment while also boosting manufacturing output and creating more jobs

Read more

  • Industrial biotech uses enzymes and micro-organisms to make products which improve the effectiveness of detergents so that clothes can be washed at lower temperatures and the production of paper and pulp, food, clothing, chemicals and bioenergy is done in a more environmentally efficient way, using less energy, less water and producing less waste.
  • Industrial biotech transforms agricultural products and organic waste into other substances with the aim of substituting the need for crude oil as a starting material to help fight global warming.
  • Industrial biotech can save energy in the production process and lead to significant reductions in greenhouse gas emissions. The WWF estimates a reduction of between 1 and 2.5 billion tonnes of C02 equivalent per year by 2030.
  • Industrial biotech offers an alternative and a safer form of global energy, vs. diminishing and volatile fossil fuels.
  • Europe is a world leader in industrial biotech and produces about 75% of the world’s enzymes.
  • Industrial biotech is worth nearly €2 trillion and provides approximately 22 million jobs in Europe alone across sectors as diverse as agriculture, forestry, fisheries, food, chemicals and biofuels.